Spot gold (XAUUSD:CUR) fell 1.5% on Friday following reports that the People’s Bank of China paused their purchases in May ...

Dycom Industries' historical financial results have demonstrated strong financial performance. Learn why DY stock is a Buy.

Savara's valuation will be heavily impacted by the results of its upcoming IMPALA-2 trial for its drug Molgramostim. Learn ...

AGNC Investment's reliance on leverage and long-term fixed-income assets makes it vulnerable to interest rate fluctuations ...

Cybersecurity stocks have not performed well recently, but I see a GARP opportunity in the HACK's historical drawdowns. Cyber ...

Cracker Barrel is facing challenges in a competitive market, and it must revitalize its brand. See why we recommend a buy on ...

Thermo Fisher Scientific is well-positioned to benefit from the demand for innovation in the healthcare and biotech sectors.

Aegis Value Fund delivered a 13.13% return in 2023, underperforming the 23.33% gain in its primary benchmark small-cap deep ...

Uber's valuation is slightly above industry peers, which trade at a median EV/Sales TTM multiple of 3.2x (vs 3.6x for Uber).

Pfizer's growth in cancer treatments, acquisitions, R&D investment despite weak Q1 financials, and legal risks in mRNA ...

Toro dropped after a short report raised concerns about inventory buildup in the dealer channel, but rebounded after 2Q ...

G-III Apparel's disappointing Q1 results and lowered Q2 sales forecast indicate potential challenges for its fiscal 2025 ...